Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Aganirsen> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Aganirsen abstract "Aganirsen (previously GS-101) is a 25 mer DNA antisense oligonucleotide therapeutic inhibiting insulin receptor substrate-1 (IRS-1), which is being investigated as a topical treatment for ocular neovascularisation. Aganirsen is a candidate for the treatment of ocular neovascularization in patients suffering from front of the eye (cornea) or back of the eye (retinal) diseases, including progressive corneal neovascularisation in patients suffering from infectious keratitis and wet age related macular degeneration (AMD).Aganirsen actively inhibits the production of IRS-1 by binding IRS-1 mRNA (antisense therapy). Aganirsen therefore induces an upstream inhibition of the neovascularization pathway, most notably by inhibiting excess VEGF and Il-1β expression.".
- Aganirsen iupacName "all-P-ambo-thymidylyl-(3′→5′)-2′-deoxy-P-thioadenylyl-(3′→5′)-P- thiothymidylyl-(3′→5′)-2′-deoxy-P-thiocytidylyl-(3′→5′)-2′-deoxy-P- thiocytidylyl-(3′→5′)-2′-deoxy-P-thioguanylyl-(3′→5′)-2′-deoxy-P- thioguanylyl-(3′→5′)-2′-deoxy-P-thioadenylyl-(3′→5′)-2′-deoxy-P- thioguanylyl-(3′→5′)-2′-deoxy-P-thioguanylyl-(3′→5′)-2′-deoxy-P- thioguanylyl-(3′→5′)-2′-deoxy-P-thiocytidylyl-(3′→5′)-P- thiothymidylyl-(3′→5′)-2′-deoxy-P-thiocytidylyl-(3′→5′)-2′-deoxy-P- thioguanylyl-(3′→5′)-2′-deoxy-P-thiocytidylyl-(3′→5′)-2′-deoxy-P- thiocytidylyl-(3′→5′)-2′-deoxy-P-thioadenylyl-(3′→5′)-P- thiothymidylyl-(3′→5′)-2′-deoxy-P-thioguanylyl-(3′→5′)-2′-deoxy-P- thiocytidylyl-(3′→5′)-P-thiothymidylyl-(3′→5′)-2′-deoxy-P- thioguanylyl-(3′→5′)-2′-deoxy-P-thiocytidylyl-(3′→5′)-P-thiothymidine".
- Aganirsen wikiPageID "41579834".
- Aganirsen wikiPageLength "7932".
- Aganirsen wikiPageOutDegree "14".
- Aganirsen wikiPageRevisionID "691445883".
- Aganirsen wikiPageWikiLink Antisense_therapy.
- Aganirsen wikiPageWikiLink Category:Nucleic_acids.
- Aganirsen wikiPageWikiLink Corneal_graft_rejection.
- Aganirsen wikiPageWikiLink Endothelium.
- Aganirsen wikiPageWikiLink IL1B.
- Aganirsen wikiPageWikiLink IRS1.
- Aganirsen wikiPageWikiLink Macular_degeneration.
- Aganirsen wikiPageWikiLink Neovascularization.
- Aganirsen wikiPageWikiLink Oligonucleotide.
- Aganirsen wikiPageWikiLink Topical_medication.
- Aganirsen wikiPageWikiLink Vascular_endothelial_growth_factor.
- Aganirsen wikiPageWikiLinkText "aganirsen".
- Aganirsen imagesize "150".
- Aganirsen iupacname "all-P-ambo-thymidylyl--2′-deoxy-P-thioadenylyl--P- thiothymidylyl--2′-deoxy-P-thiocytidylyl--2′-deoxy-P- thiocytidylyl--2′-deoxy-P-thioguanylyl--2′-deoxy-P- thioguanylyl--2′-deoxy-P-thioadenylyl--2′-deoxy-P- thioguanylyl--2′-deoxy-P-thioguanylyl--2′-deoxy-P- thioguanylyl--2′-deoxy-P-thiocytidylyl--P- thiothymidylyl--2′-deoxy-P-thiocytidylyl--2′-deoxy-P- thioguanylyl--2′-deoxy-P-thiocytidylyl--2′-deoxy-P- thiocytidylyl--2′-deoxy-P-thioadenylyl--P- thiothymidylyl--2′-deoxy-P-thioguanylyl--2′-deoxy-P- thiocytidylyl--P-thiothymidylyl--2′-deoxy-P- thioguanylyl--2′-deoxy-P-thiocytidylyl--P-thiothymidine".
- Aganirsen wikiPageUsesTemplate Template:Chembox.
- Aganirsen wikiPageUsesTemplate Template:Chembox_Hazards.
- Aganirsen wikiPageUsesTemplate Template:Chembox_Identifiers.
- Aganirsen wikiPageUsesTemplate Template:Chembox_Properties.
- Aganirsen wikiPageUsesTemplate Template:Reflist.
- Aganirsen subject Category:Nucleic_acids.
- Aganirsen hypernym Antisense.
- Aganirsen type ChemicalCompound.
- Aganirsen type ChemicalSubstance.
- Aganirsen type ChemicalObject.
- Aganirsen type Thing.
- Aganirsen type Q11173.
- Aganirsen comment "Aganirsen (previously GS-101) is a 25 mer DNA antisense oligonucleotide therapeutic inhibiting insulin receptor substrate-1 (IRS-1), which is being investigated as a topical treatment for ocular neovascularisation.".
- Aganirsen label "Aganirsen".
- Aganirsen sameAs Q15633943.
- Aganirsen sameAs m.0_1kcy3.
- Aganirsen sameAs Q15633943.
- Aganirsen wasDerivedFrom Aganirsen?oldid=691445883.
- Aganirsen isPrimaryTopicOf Aganirsen.